Sales and Marketing

Showing 15 posts of 11528 posts found.

Business Intelligence Awards launched

August 23, 2006 Sales and Marketing BHBIA

The first ever awards for business intelligence and market research in the UK pharmaceutical industry have been launched to recognise …

New broom Kindler sweeps away Pfizer bureaucracy

August 21, 2006 Research and Development, Sales and Marketing

Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …

Head-to-head: Nice and the SMC

August 16, 2006 Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …

NICE gives breast cancer drugs the green light

August 15, 2006 Sales and Marketing

Aromatase inhibitors are to become more widely available for post-menopausal women with early breast cancer.As expected, NICE's final appraisal determination …

Generic version of Plavix launched in US

August 10, 2006 Sales and Marketing

A generic company has launched a version of blood-thinning blockbuster product Plavix in the US, threatening the $3.3 billion sales …

GSK delivers strong quarterly performance

August 9, 2006 Sales and Marketing

GlaxoSmithKline's pharmaceutical sales rose by 10% in this year's second quarter earning the company a total of five billion pounds.Sales …

Lilly’s new products drive up sales

August 8, 2006 Sales and Marketing

Accelerated sales of predicted blockbuster depression treatment Cymbalta have helped boost Lilly sales for the second quarter of 2006.The drug …

Identifying and nurturing talent in your salesforce

August 7, 2006 Sales and Marketing Schering-Plough, UK, sales, strategy

The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …

Takeda selects London for new European business

August 4, 2006 Sales and Marketing

Japanese pharmaceutical company Takeda has chosen London as the site of its new four million pound European sales and marketing …

McKinnell makes early exit from Pfizer

August 3, 2006 Sales and Marketing Pfizer

Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …

Pfizer’s Sutent receives conditional EMEA approval

August 3, 2006 Sales and Marketing

 Pfizer's new kidney cancer drug Sutent is rapidly catching up with its recently approved rival, Bayer's Nexavar.Sutent (sunitinib) has been …

Crestor leads AZ European sales growth

August 3, 2006 Sales and Marketing

Crestor was AstraZeneca's most rapidly expanding product in terms of European sales in the second quarter of this year.  Sales …

Pfizer’s smoking-cessation drug a step closer to European approval

August 3, 2006 Sales and Marketing

Pfizer's potential blockbuster smoking cessation drug Champix has been recommended for European approval by a key EMEA committee.The first-in-class treatment …

Study boost for AstraZeneca’s Nexium

August 1, 2006 Sales and Marketing

AstraZeneca's blockbuster gastro-oesophageal reflux disease treatment Nexium has come out ahead of Wyeth's Zoton in a new study, which showed …

First cervical cancer vaccine close to European approval

August 1, 2006 Sales and Marketing

The first-ever cervical cancer vaccine is set for approval in Europe following its recommendation from a key advisory committee.The positive …
The Gateway to Local Adoption Series

Latest content